Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease.

B. Ranchoux (Quebec, Canada), V. Nadeau (Quebec, Canada), S. Breuils-Bonnet (Quebec, Canada), J. Omura (Quebec, Canada), M. André (Quebec, Canada), J. Dupuis (Montreal, Canada), P. Pibarot (Quebec, Canada), R. Paulin (Quebec, Canada), O. Boucherat (Quebec, Canada), S. Provencher (Quebec, Canada), S. Archer (Quebec, Canada), S. Bonnet (Quebec, Canada), F. Potus (Kingston, Canada)

Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Session: Pulmonary hypertension: new therapeutic pathways and modalities
Session type: Thematic Poster
Number: 3949
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Ranchoux (Quebec, Canada), V. Nadeau (Quebec, Canada), S. Breuils-Bonnet (Quebec, Canada), J. Omura (Quebec, Canada), M. André (Quebec, Canada), J. Dupuis (Montreal, Canada), P. Pibarot (Quebec, Canada), R. Paulin (Quebec, Canada), O. Boucherat (Quebec, Canada), S. Provencher (Quebec, Canada), S. Archer (Quebec, Canada), S. Bonnet (Quebec, Canada), F. Potus (Kingston, Canada). Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease.. 3949

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: